神経障害性疼痛：製薬企業動向...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 10
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers – Global Issues 22
4 Current and Future Players 25
4.1 Overview 25
4.2 Trends in Corporate Strategy 27
4.3 Company Profiles 28
4.3.1 Pfizer 28
4.3.2 Eli Lilly 30
4.3.3 Grünenthal 32
4.3.4 Endo Health Solutions 35
4.3.5 Janssen Pharmaceuticals 36
4.3.6 Daiichi Sankyo 38
4.3.7 Convergence Pharmaceuticals 40
5 Appendix 42
5.1 Bibliography 42
5.2 Abbreviations 43
5.3 Methodology 44
5.4 Forecasting Methodology 44
5.4.1 Diagnosed PDN, PHN, and TN Patients 44
5.4.2 Percent Drug-Treated Patients 45
5.4.3 General Pricing Assumptions 45
5.4.4 Generic Erosion 45
5.5 Physicians and Specialists Included in This Study 46
5.6 About the Authors 48
5.6.1 Author 48
5.6.2 Global Head of Healthcare 49
5.7 About GlobalData 50
5.8 Disclaimer 50